Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth

Published:2005-07 Issue:1 Volume:63 Page:39-44
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Greenman Y.,Tordjman K.,Osher E.,Veshchev I.,Shenkerman G.,Reider-Groswasser I. I.,Segev Y.,Ouaknine G.,Stern N.

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2005.02295.x/fullpdf

Reference24 articles.

1. An audit of selected patients with non-functioning pituitary adenoma treated by transsphenoidal surgery without irradiation

2. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - a follow-up study

3. Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth

4. DIAGNOSIS AND MANAGEMENT OF NONFUNCTIONING PITUITARY TUMORS

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Peculiar Case of Cabergoline Response to a Non-functioning Cystic Pituitary Adenoma in a Young Adult Male;Cureus;2024-08-27

2. Clinical and therapeutic implications of cavernous sinus invasion in pituitary adenomas;Endocrine;2024-05-18

3. Pharmacological Treatment of Non-Functioning Pituitary Adenomas;Archives of Medical Research;2023-12

4. A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells;Cancers;2023-06-16

5. Treatment of non-functioning pituitary adenoma with cabergoline: a systematic review and meta-analysis;Pituitary;2022-07-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3